Table 2 Baseline characteristics of the participants a
Variable | Olive Oil group (n = 22) | Canola Oil group (n = 20) | P-value b |
|---|---|---|---|
Age (year) | 55.09 ± 6.92 | 59.30 ± 5.84 | 0.44 |
Sex (Male) | 20 (91%) | 18 (90%) | 0.66 |
PCI history | 16 (73%) | 16 (80%) | 0.89 |
CABG history | 2 (9.1%) | 1 (5%) | 0.86 |
Diabetes Mellitus | 8 (36%) | 8 (40%) | 0.91 |
Hypertension | 11 (50%) | 11 (55%) | 0.92 |
Dyslipidemia | 12 (54%) | 8 (40%) | 0.55 |
Overweight | 16 (73%) | 11 (55%) | 0.19 |
Smoking | 8 (36%) | 4 (20%) | 0.30 |
Medications: | |||
 Aspirin | 21 (95%) | 20 (100%) | 0.93 |
 Clopidogrel | 15 (68%) | 10 (50%) | 0.29 |
 Statins | 20 (91%) | 19 (95%) | 0.93 |
 ACEI | 9 (41%) | 4 (20%) | 0.12 |
 ARB | 10 (45%) | 13 (65%) | 0.42 |
 BB | 15 (68%) | 15 (75%) | 0.81 |
 Nitrates | 7 (31%) | 7 (35%) | 0.90 |
 Aldosteron Antagonist | 5 (22%) | 1 (5%) | 0.17 |